Latest Breaking News On - அட்மாஸ் மருந்துகள் இன்க் - Page 1 : comparemela.com

Parkinson s Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027 - FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 5, 2021 /PRNewswire/ Parkinson s disease (PD) is a neurodegenerative disorder that affects predominately dopamine-producing ( dopaminergic ) neurons in a specific area of the brain called substantia nigra. Symptoms generally develop slowly over years. The progression of symptoms is often a bit different from one person to another due to the diversity of the disease. According to the Parkinson s Foundation, people with PD may experience: tremors, mainly at rest and described as pill rolling tremor in hands, plus gait and balance problems. The cause remains largely unknown. Although there is no cure, treatment options vary and include medications and surgery. While Parkinson s itself is not fatal, disease complications can be serious. The Centers for Disease Control and Prevention (CDC) rated complications from PD as the 14th cause of

United statesCharles strongoKostenloser wertpapierhandelRay dorseyPrnewswire parkinsonUniversity of californiaCompany new drug applicationParkinson disease biomarkers programUniversity of rochester medical centerFn media groupMental health monthParkinson movement disorder allianceAdamas pharmaceuticals incCenters for diseaseGlobal wholehealth partners corpNeurocrine biosciences inc